Silence Therapeutics Plc's

• SLN's Stock Performance relative to its Competitors

Exicure Inc Share Performance -74.56% One Year

Exicure Inc Profile Exicure Inc operates on a business model focused on developing and commercializing transformative gene therapy drugs utilizing its proprietary spherical nucleic acid (SNA) technology. The company aims to leverage its platform to create therapeutic solutions for various diseases by delivering genetic medicines directly to cells. By collaborating with partners or independently, Exicure Inc aims to advance its pipeline and ultimately bring innovative treatments to the market. More about Exicure Inc 's Market Share

Mirum Pharmaceuticals Inc Share Performance +31.58% One Year

Mirum Pharmaceuticals Inc Profile Mirum Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing innovative therapies for patients with rare liver diseases. More about Mirum Pharmaceuticals Inc 's Market Share

Lexicon Pharmaceuticals Inc Share Performance +96.93% This Year

Lexicon Pharmaceuticals Inc Profile Lexicon Pharmaceuticals Inc is a biopharmaceutical company that focuses on the discovery and development of innovative drugs. Their business model revolves around identifying potential drug targets, conducting research and preclinical studies to validate these targets, and subsequently developing drugs through clinical trials for various therapeutic areas. They also collaborate with pharmaceutical companies for joint development and commercialization efforts, aiming to bring these drugs to market and improve patient outcomes. More about Lexicon Pharmaceuticals Inc 's Market Share

Kyntra Bio Inc Share Performance +20.95% 30 Days

Kyntra Bio Inc Profile The company conducts preclinical development and clinical trials for its product candidates. More about Kyntra Bio Inc 's Market Share

Kalvista Pharmaceuticals Inc Share Performance +0.75% 30 Days

Kalvista Pharmaceuticals Inc Profile Kalvista Pharmaceuticals Inc's business model primarily focuses on the development and commercialization of novel small molecule therapies for various diseases. They strive to discover and develop innovative treatments to address unmet medical needs, and aim to bring these therapies to market efficiently and effectively. More about Kalvista Pharmaceuticals Inc 's Market Share

Sources: Silence Therapeutics Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Wednesday, September 2, 2026 10:23 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Silence Therapeutics Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.